Condensed Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities:
Net loss	$ (130,000)	$ (252,000)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation	70,000	85,000
Loss on disposal of fixed assets	0	41,000
Amortization of debt issuance costs	187,000	216,000
Provision for bad debts	(1,000)	(12,000)
Provision for slow moving and obsolete inventory	63,000	30,000
Share-based payment expense	27,000	30,000
Changes in:
Accounts receivable	13,000	105,000
Inventory	(189,000)	189,000
Prepaid expenses and other current assets	5,000	3,000
Accounts payable	19,000	(87,000)
Accrued expenses and other current liabilities	18,000	(191,000)
Wages payable	23,000	47,000
Net cash provided by operating activities	105,000	204,000
Cash flows from investing activities:
Proceeds from sale of equipment	0	10,000
Purchase of property, plant and equipment	(10,000)	(21,000)
Patent application costs	(4,000)	(11,000)
Net cash used in investing activities	(14,000)	(22,000)
Cash flows from financing activities:
Proceeds from / (Payments on) debt financing	130,000	(183,000)
Deferred finance costs	(205,000)	(7,000)
Proceeds from lines of credit	5,090,000	5,082,000
Payments on lines of credit	(5,234,000)	(5,287,000)
Net cash used in financing activities	(219,000)	(395,000)
Net decrease in cash and cash equivalents	(128,000)	(213,000)
Cash and cash equivalents - beginning of period	352,000	646,000
Cash and cash equivalents - end of period	224,000	433,000
Supplemental disclosures of cash flow information
Cash paid during period for interest	$ 176,000	$ 186,000